Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.
Guerra I, Barros F, Chaparro M, Benítez JM, Martín-Arranz MD, de Francisco R, Piqueras M, de Castro L, Carbajo AY, Bermejo F, Mínguez M, Gutiérrez A, Mesonero F, Cañete F, González-Muñoza C, Calvo M, Sicilia B, Alfambra E, Rivero M, Lucendo AJ, Tardillo CA, Almela P, Bujanda L, van Domselaar M, Ramos L, Fernández Sánchez M, Hinojosa E, Verdejo C, Gimenez A, Rodríguez-Lago I, Manceñido N, Pérez Calle JL, Moreno MDP, Delgado-Guillena PG, Antolín B, Ramírez de la Piscina P, Casanova MJ, Soto Escribano P, Martín Arranz E, Pérez-Martínez I, Mena R, García Morales N, Granja A, Boscá Watts MM, Francés R, Fernández C, Calafat M, Roig-Ramos C, Vera MI, Carracedo Á, Domènech E, Gisbert JP; ENEIDA Project of GETECCU. Guerra I, et al. Among authors: granja a. Dig Dis. 2024;42(3):257-264. doi: 10.1159/000537782. Epub 2024 Mar 8. Dig Dis. 2024. PMID: 38452742
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.
Ferreiro-Iglesias R, Porto Silva S, Marín S, Casanova MJ, Mañosa M, González-Muñoza C, de Francisco R, Caballol B, Arias L, Piqueras M, Zabana Y, Rivero M, Calvet X, Mesonero F, Varela Trastoy P, Busta Nistal R, Gómez Perosanz R, Vega P, Gonzalez-Vivo M, Iborra M, Bermejo F, Madero L, Rodríguez-Lago I, Rodríguez Gonzalez M, Vera I, Ponferrada Díaz Á, Vela M, Torrealba Medina L, Van Domselaar M, Gomollón F, Iglesias E, Gisbert JP, Calafat M, Giordano A, Pérez-Martínez I, Ricart E, Sicilia B, Mena R, Esteve M, Rivas C, Brunet-Mas E, Fernández C, de Jorge Turrión MÁ, Velayos Jiménez B, Quiñones Calvo M, Regueiro Expósito C, Márquez-Mosquera L, Nos P, Granja A, Gutiérrez A, Cabriada JL, Hervías Cruz D, Calvo M, Pérez Pérez J, Rodríguez Díaz Y, Busquets Casal D, Menacho M, Leal C, Lucendo AJ, Royo V, Olivares S, Álvarez Herrero B, Carrillo-Palau M, Gilabert Álvarez P, Manceñido Marcos N, Martínez-Pérez TJ, Muñoz Villafranca MC, Almela P, Argüelles-Arias F, Legido J, Fuentes Coronel AM, Nieto L, Domènech E, Barreiro-de Acosta M; ENEIDA project sponsored by GETECCU. Ferreiro-Iglesias R, et al. Among authors: granja a. Aliment Pharmacol Ther. 2024 Sep;60(5):604-612. doi: 10.1111/apt.18133. Epub 2024 Jun 28. Aliment Pharmacol Ther. 2024. PMID: 38943230
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I. Bermejo F, et al. Among authors: granja a. Inflamm Bowel Dis. 2022 Jan 5;28(1):41-47. doi: 10.1093/ibd/izab015. Inflamm Bowel Dis. 2022. PMID: 33528018
Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Bermejo F, Jiménez L, Algaba A, Vela M, Bastida G, Merino O, López-García A, Melcarne L, Rodríguez-Lago I, de la Maza S, Bouhmidi A, Barreiro-de Acosta M, López-Serrano P, Carrillo-Palau M, Mesonero F, Orts B, Bonillo D, Granja A, Guerra I. Bermejo F, et al. Among authors: granja a. Inflamm Bowel Dis. 2022 Jan 5;28(1):150. doi: 10.1093/ibd/izab242. Inflamm Bowel Dis. 2022. PMID: 34636902 No abstract available.
Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease.
Algaba A, Romero S, Granja A, Garza D, Aller M, Barrero S, Guerra I, Gil M, Pizarro N, Ruiz P, Prieto S, Hernández B, Pou A, Bermejo F. Algaba A, et al. Among authors: granja a. Gastroenterol Hepatol. 2023 Jan;46(1):48-53. doi: 10.1016/j.gastrohep.2022.05.006. Epub 2022 May 20. Gastroenterol Hepatol. 2023. PMID: 35605819 Free PMC article. English, Spanish.
Synthesis, fluorescence and theoretical insights into a novel FRET-based dansyl-rhodamine sensor for the in vitro detection of toxic bioaccumulated Hg(II) ions.
Martins F, Granja A, Reis S, Gameiro P, Barone G, Neves MGPMS, Silva AMG. Martins F, et al. Among authors: granja a. Spectrochim Acta A Mol Biomol Spectrosc. 2024 Dec 2;329:125534. doi: 10.1016/j.saa.2024.125534. Online ahead of print. Spectrochim Acta A Mol Biomol Spectrosc. 2024. PMID: 39662194
HPV and coronary diseases in menopausal women: an integrative review.
Granja AN, Lima ABR, Martins PVB, Salgado BJL, da Costa RMG, Brito HO, Salgado N. Granja AN, et al. Rev Bras Ginecol Obstet. 2024 Jul 26;46:e-rbgo57. doi: 10.61622/rbgo/2024rbgo57. eCollection 2024. Rev Bras Ginecol Obstet. 2024. PMID: 39176203 Free PMC article. Review.
Magnetic carbon nanotubes modified with proteins and hydrophilic monomers: Cytocompatibility, in-vitro toxicity assays and permeation across biological interfaces.
Rosa MA, Granja A, Nunes C, Reis S, da Silva ABS, Leal KNDS, Arruda MAZ, Gorup LF, Santos MG, Dias MVS, Figueiredo EC. Rosa MA, et al. Among authors: granja a. Int J Biol Macromol. 2024 Jun;269(Pt 1):131962. doi: 10.1016/j.ijbiomac.2024.131962. Epub 2024 Apr 29. Int J Biol Macromol. 2024. PMID: 38692550
78 results